Teladoc Health, Inc. $TDOC Stake Trimmed by Intech Investment Management LLC

Intech Investment Management LLC reduced its position in Teladoc Health, Inc. (NYSE:TDOC) by 20.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 92,834 shares of the health services provider’s stock after selling 23,445 shares during the period. Intech Investment Management LLC owned about 0.05% of Teladoc Health worth $809,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in TDOC. Vanguard Group Inc. grew its position in Teladoc Health by 7.0% during the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock worth $157,229,000 after purchasing an additional 1,289,183 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Teladoc Health by 2.1% in the second quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider’s stock worth $36,153,000 after buying an additional 84,356 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Teladoc Health by 5.2% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,571,673 shares of the health services provider’s stock valued at $20,471,000 after buying an additional 127,960 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its position in Teladoc Health by 14.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,558,369 shares of the health services provider’s stock valued at $12,405,000 after buying an additional 200,494 shares during the period. Finally, Nuveen LLC purchased a new stake in Teladoc Health in the 1st quarter worth about $11,789,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Evercore ISI lowered their target price on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research note on Thursday, October 30th. Zacks Research downgraded shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Bank of America cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday. BMO Capital Markets began coverage on shares of Teladoc Health in a report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target on the stock. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research note on Tuesday. Five investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $9.68.

Teladoc Health Price Performance

Shares of Teladoc Health stock opened at $7.46 on Thursday. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. The firm has a fifty day simple moving average of $8.09 and a 200-day simple moving average of $7.76. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of -5.82 and a beta of 1.92. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. The business had revenue of $626.44 million for the quarter, compared to analyst estimates of $625.66 million. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The firm’s revenue for the quarter was down 2.2% on a year-over-year basis. During the same period in the previous year, the company posted ($0.19) earnings per share. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, sell-side analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.